Logo image of TRSG

TUNGRAY TECHNOLOGIES INC-A (TRSG) Stock Fundamental Analysis

NASDAQ:TRSG - KYG9124M1069 - Common Stock

1.6553 USD
-0.01 (-0.87%)
Last: 8/27/2025, 8:21:01 PM
Fundamental Rating

1

TRSG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. TRSG may be in some trouble as it scores bad on both profitability and health. TRSG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

TRSG had negative earnings in the past year.
In the past year TRSG has reported a negative cash flow from operations.
TRSG Yearly Net Income VS EBIT VS OCF VS FCFTRSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M 4M

1.2 Ratios

TRSG's Return On Assets of -4.33% is in line compared to the rest of the industry. TRSG outperforms 41.94% of its industry peers.
The Return On Equity of TRSG (-7.43%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.33%
ROE -7.43%
ROIC N/A
ROA(3y)4.17%
ROA(5y)N/A
ROE(3y)7.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRSG Yearly ROA, ROE, ROICTRSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

TRSG has a Gross Margin of 44.59%. This is in the better half of the industry: TRSG outperforms 76.61% of its industry peers.
TRSG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TRSG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.23%
GM growth 5YN/A
TRSG Yearly Profit, Operating, Gross MarginsTRSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

TRSG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TRSG has more shares outstanding
Compared to 1 year ago, TRSG has an improved debt to assets ratio.
TRSG Yearly Shares OutstandingTRSG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
TRSG Yearly Total Debt VS Total AssetsTRSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

TRSG has an Altman-Z score of 2.83. This is not the best score and indicates that TRSG is in the grey zone with still only limited risk for bankruptcy at the moment.
TRSG has a Altman-Z score of 2.83. This is comparable to the rest of the industry: TRSG outperforms 41.94% of its industry peers.
TRSG has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.07, TRSG perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 2.83
ROIC/WACCN/A
WACC9.38%
TRSG Yearly LT Debt VS Equity VS FCFTRSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

TRSG has a Current Ratio of 1.86. This is a normal value and indicates that TRSG is financially healthy and should not expect problems in meeting its short term obligations.
TRSG has a worse Current ratio (1.86) than 62.90% of its industry peers.
TRSG has a Quick Ratio of 1.66. This is a normal value and indicates that TRSG is financially healthy and should not expect problems in meeting its short term obligations.
TRSG's Quick ratio of 1.66 is in line compared to the rest of the industry. TRSG outperforms 50.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.66
TRSG Yearly Current Assets VS Current LiabilitesTRSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

0

3. Growth

3.1 Past

The earnings per share for TRSG have decreased strongly by -215.55% in the last year.
TRSG shows a decrease in Revenue. In the last year, the revenue decreased by -7.47%.
The Revenue has been decreasing by -9.82% on average over the past years.
EPS 1Y (TTM)-215.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.71%
Revenue 1Y (TTM)-7.47%
Revenue growth 3Y-9.82%
Revenue growth 5YN/A
Sales Q2Q%-10.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TRSG Yearly Revenue VS EstimatesTRSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TRSG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRSG Price Earnings VS Forward Price EarningsTRSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRSG Per share dataTRSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TRSG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TUNGRAY TECHNOLOGIES INC-A

NASDAQ:TRSG (8/27/2025, 8:21:01 PM)

1.6553

-0.01 (-0.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.04%
Inst Owner ChangeN/A
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap27.06M
AnalystsN/A
Price TargetN/A
Short Float %0.61%
Short Ratio1.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.48
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.12
BVpS1.07
TBVpS1.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.33%
ROE -7.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.59%
FCFM N/A
ROA(3y)4.17%
ROA(5y)N/A
ROE(3y)7.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.23%
GM growth 5YN/A
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.74%
Cap/Sales 2.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.66
Altman-Z 2.83
F-Score2
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)46.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.7%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-152.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.47%
Revenue growth 3Y-9.82%
Revenue growth 5YN/A
Sales Q2Q%-10.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-231.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-445.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-280.02%
OCF growth 3YN/A
OCF growth 5YN/A